Implanted markers prior to neoadjuvant chemotherapy: preliminary report

DM Allan for the Dartford Breast Care
2000 Breast Cancer Research  
Although there are numerous publications regarding the value (and limitations) of MRI in the diagnosis of a variety of breast conditions, access to MRI in the UK is severely limited. Because prioritisation of all cases needing MRI is necessary, only those that will lead to a clear alteration in clinical management can be justified. Against this background, the current use of MRI in a busy symptomatic and screening practice will be presented and justified.
doi:10.1186/bcr234 fatcat:wbyztgyx2zh6paqv4amzhopmyi